Ethinyl estradiol and norelgestromin transdermal and Pitolisant Hydrochloride
Determining the interaction of Ethinyl estradiol and norelgestromin transdermal and Pitolisant Hydrochloride and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.ADDITIONAL CONTRACEPTION RECOMMENDED: Coadministration with pitolisant may decrease the plasma concentrations of contraceptive hormones. The proposed mechanism is induction of the CYP450 3A4-mediated metabolism of estrogens and progestins by pitolisant and its main metabolites. MANAGEMENT: The manufacturer recommends that alternative, nonhormonal methods of effective contraception should be used during and for at least 21 days after pitolisant therapy. References "Product Information. Wakix (pitolisant)." Harmony Biosciences, LLC, Plymouth Meeting, PA. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 Faculty of Sexual & Reproductive Healthcare "FSRH Clinical Guidance: Drug Interactions with Hormonal Contraception. Available from: URL: file:///C:/Users/df033684/Downloads/ceuguidancedruginteractionshormonal.pdf." ([2012, Jan 1]):
Professional:ADDITIONAL CONTRACEPTION RECOMMENDED: Coadministration with pitolisant may decrease the plasma concentrations of contraceptive hormones. The proposed mechanism is induction of the CYP450 3A4-mediated metabolism of estrogens and progestins by pitolisant and its main metabolites.
MANAGEMENT: The manufacturer recommends that alternative, nonhormonal methods of effective contraception should be used during and for at least 21 days after pitolisant therapy.
- "Product Information. Wakix (pitolisant)." Harmony Biosciences, LLC, Plymouth Meeting, PA.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Faculty of Sexual & Reproductive Healthcare "FSRH Clinical Guidance: Drug Interactions with Hormonal Contraception. Available from: URL: file:///C:/Users/df033684/Downloads/ceuguidancedruginteractionshormonal.pdf." ([2012, Jan 1]):
Generic Name: ethinyl estradiol / norelgestromin
Brand name: Xulane, Ortho Evra
Synonyms: Ethinyl estradiol and norelgestromin (transdermal), Ethinyl Estradiol and Norelgestromin
Generic Name: pitolisant
Brand name: Wakix
Synonyms: Pitolisant
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ethinyl estradiol and norelgestromin transdermal-Pitressin
- Ethinyl estradiol and norelgestromin transdermal-Pitressin Injection
- Ethinyl estradiol and norelgestromin transdermal-Pitressin Synthetic
- Ethinyl estradiol and norelgestromin transdermal-Placidyl
- Ethinyl estradiol and norelgestromin transdermal-Plan B
- Ethinyl estradiol and norelgestromin transdermal-Plan B One-Step
- Pitolisant Hydrochloride-Ethinyl estradiol and norethindrone
- Pitolisant Hydrochloride-Ethinyl estradiol and norethindrone birth control
- Pitolisant Hydrochloride-Ethinyl Estradiol and Norethindrone Chewable Tabs & Ferrous Fumarate Tabs
- Pitolisant Hydrochloride-Ethinyl estradiol and norethindrone HRT
- Pitolisant Hydrochloride-Ethinyl Estradiol and Norethindrone Tablets
- Pitolisant Hydrochloride-Ethinyl estradiol and norgestimate